Envestnet Asset Management
IBB icon

Envestnet Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$7.09M Buy
56,079
+3,051
+6% +$386K ﹤0.01% 1966
2025
Q1
$6.78M Sell
53,028
-3,941
-7% -$504K ﹤0.01% 1917
2024
Q4
$7.53M Buy
56,969
+1,138
+2% +$150K ﹤0.01% 1830
2024
Q3
$8.13M Sell
55,831
-6,827
-11% -$994K ﹤0.01% 1782
2024
Q2
$8.6M Sell
62,658
-4,135
-6% -$568K ﹤0.01% 1655
2024
Q1
$9.17M Buy
66,793
+9,067
+16% +$1.24M ﹤0.01% 1580
2023
Q4
$7.84M Sell
57,726
-13,231
-19% -$1.8M ﹤0.01% 1591
2023
Q3
$8.68M Sell
70,957
-18,407
-21% -$2.25M ﹤0.01% 1466
2023
Q2
$11.3M Sell
89,364
-4,697
-5% -$596K 0.01% 1223
2023
Q1
$12.1M Sell
94,061
-101,304
-52% -$13.1M 0.01% 1135
2022
Q4
$25.6M Buy
195,365
+35,253
+22% +$4.63M 0.01% 730
2022
Q3
$18.7M Buy
160,112
+35,655
+29% +$4.17M 0.01% 812
2022
Q2
$14.6M Sell
124,457
-14,449
-10% -$1.7M 0.01% 955
2022
Q1
$18.1M Sell
138,906
-17,504
-11% -$2.28M 0.01% 891
2021
Q4
$23.9M Buy
156,410
+8,915
+6% +$1.36M 0.01% 765
2021
Q3
$23.8M Sell
147,495
-5,887
-4% -$952K 0.01% 721
2021
Q2
$25.1M Sell
153,382
-27,468
-15% -$4.5M 0.01% 693
2021
Q1
$27.2M Sell
180,850
-102,414
-36% -$15.4M 0.02% 606
2020
Q4
$42.9M Sell
283,264
-151,813
-35% -$23M 0.03% 389
2020
Q3
$58.9M Buy
435,077
+14,393
+3% +$1.95M 0.05% 275
2020
Q2
$57.5M Buy
420,684
+328,599
+357% +$44.9M 0.06% 257
2020
Q1
$9.92M Buy
92,085
+11,882
+15% +$1.28M 0.01% 685
2019
Q4
$9.67M Buy
80,203
+1,755
+2% +$211K 0.01% 820
2019
Q3
$7.81M Sell
78,448
-13,182
-14% -$1.31M 0.01% 867
2019
Q2
$10M Sell
91,630
-3,304
-3% -$360K 0.01% 732
2019
Q1
$10.6M Buy
94,934
+23,011
+32% +$2.57M 0.01% 667
2018
Q4
$6.94M Buy
71,923
+53,935
+300% +$5.2M 0.01% 755
2018
Q3
$2.19M Sell
17,988
-7,601
-30% -$927K ﹤0.01% 593
2018
Q2
$2.81M Buy
25,589
+7
+0% +$769 0.01% 695
2018
Q1
$2.67M Sell
25,582
-4,305
-14% -$449K 0.01% 607
2017
Q4
$3.19M Sell
29,887
-20,470
-41% -$2.19M 0.01% 766
2017
Q3
$16.8M Buy
50,357
+8,897
+21% +$2.97M 0.04% 262
2017
Q2
$12.9M Buy
41,460
+6,917
+20% +$2.15M 0.04% 312
2017
Q1
$10.1M Buy
34,543
+12,773
+59% +$3.75M 0.03% 360
2016
Q4
$5.78M Buy
21,770
+6,519
+43% +$1.73M 0.02% 493
2016
Q3
$4.41M Buy
15,251
+1,496
+11% +$433K 0.02% 632
2016
Q2
$3.54M Buy
13,755
+1,560
+13% +$401K 0.01% 778
2016
Q1
$3.18M Sell
12,195
-22,319
-65% -$5.82M 0.01% 759
2015
Q4
$11.7M Sell
34,514
-51,505
-60% -$17.4M 0.05% 303
2015
Q3
$26.1M Sell
86,019
-22,031
-20% -$6.68M 0.13% 137
2015
Q2
$39.9M Buy
108,050
+15,313
+17% +$5.65M 0.19% 108
2015
Q1
$31.8M Buy
92,737
+49,354
+114% +$16.9M 0.16% 133
2014
Q4
$13.2M Sell
43,383
-7,569
-15% -$2.3M 0.13% 124
2014
Q3
$13.9M Buy
50,952
+15,111
+42% +$4.13M 0.14% 137
2014
Q2
$9.21M Buy
35,841
+31,201
+672% +$8.02M 0.1% 166
2014
Q1
$1.1M Buy
4,640
+2,074
+81% +$490K 0.01% 436
2013
Q4
$583K Sell
2,566
-4,013
-61% -$912K 0.01% 587
2013
Q3
$1.38M Buy
6,579
+3,783
+135% +$793K 0.02% 343
2013
Q2
$486K Buy
+2,796
New +$486K 0.01% 581